Nasdaq: BEAM
Beam Therapeutics insiders
The officers, directors and 10% owners of Beam Therapeutics Inc. who hold the most stock, valued at the live BEAM price.
$20.94
BEAM today −$70K (−0.33%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 3
- Their BEAM stock
- $29.9M
- Market value
- $2.22B
- Held by ranked insiders
- 1.35%
Insiders by value of BEAM holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | John M. Evans | CEO | 1,150,205 | $24.1M | 1.09% | 4509th |
| 2 | Giuseppe Ciaramella | President | 253,911 | $5.3M | 0.24% | 13852nd |
| 3 | Kristina Burow | Director | 26,011 | $545K | <0.1% | 12281st |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Beam Therapeutics; see each profile for the filing.